5174 completed, 1066 terminated, 1025 unknown, 980 recruiting. 9573 Phase 2, 1816 Phase 1, 1027 Phase 3.
Follow Nervous System Diseases: new trials by email Literature Review of Nervous System Diseases trials Research Report on Nervous System Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ketamine and Midazolam Infusions for CRPS: Feasibility Study Ketamine, Midazolam, Normal Saline - Complex Regional Pain Syndromes | Phase 2 | Withdrawn | Stanford University | 2099-01-01 | 2024-11-22 | |
| Terazosin And Metabolic Energetics in Parkinson's Disease Terazosin 5 MG, Placebo - Parkinson's Disease (PD) | Phase 2 | Suspended | Ergun Y. Uc | 120 | 2028-07-01 | 2026-10-09 |
| Device for Bladder Control for Men With SCI Noninvasive electrical stimulation device to improve bladder control - Neurogenic Bladder | Phase 1 / Phase 2 | Not yet recruiting | VA Office of Research and Development | 12 | 2028-06-01 | 2026-06-25 |
| Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety | Phase 2 | Not yet recruiting | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 60 | 2028-05-25 | 2025-11-25 |
| Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma JBI-778 - Brain Metastases From Solid Tumors, Leptomeningeal Disease | Phase 1 / Phase 2 | Not yet recruiting | Jubilant Therapeutics Inc. | 113 | 2028-04-01 | 2026-08-07 |
| Sodium Lactate in Severe TBI Sodium Lactate, placebo - Traumatic Brain Injury | Phase 2 | Not yet recruiting | University of California, Los Angeles | 264 | 2028-01-10 | 2026-01-16 |
| Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients. Gemfibrozil, Placebo - Parkinson Disease | Phase 2 | Withdrawn | Forest Hills Lab | 2027-11-01 | 2026-08-19 | |
| Terazosin for Dementia With Lewy Bodies Terazosin Hydrochloride, Placebo - Dementia With Lewy Bodies | Phase 1 / Phase 2 | Not yet recruiting | Qiang Zhang | 40 | 2027-10-01 | 2026-03-12 |
| Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries | Phase 2 / Phase 3 | Not yet recruiting | VA Office of Research and Development | 300 | 2027-10-01 | 2026-08-04 |
| AV-1959R Vaccine in Individuals With Preclinical Alzheimer's Disease AV-1959R, Placebo - Preclinical Alzheimer's Disease, Alzheimer Disease | Phase 2 | Not yet recruiting | Institute for Molecular Medicine | 160 | 2027-10-01 | 2026-10-21 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects With Early Parkinson's Disease MT101-5 - Parkinson's Disease | Phase 2 | Not yet recruiting | Mthera Pharma Co., Ltd. | 120 | 2027-09-01 | 2026-10-16 |
| Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury Istradefylline, low oxygen therapy - Spinal Cord Injuries, Myelopathy | Phase 1 / Phase 2 | Not yet recruiting | Randy Trumbower, PT, PhD | 40 | 2027-09-01 | 2026-03-20 |
| First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant Otic neural progenitors, cochlear implantation - Sensorineural Hearing Loss, Presbyacusis | Phase 1 / Phase 2 | Not yet recruiting | Rinri Therapeutics | 20 | 2027-09-01 | 2026-10-01 |
| Terazosin And Metabolic Engagement in Alzheimer's Disease Terazosin (Hytrin), Placebo - Alzheimer s Disease | Phase 2 | Not yet recruiting | Qiang Zhang | 100 | 2027-08-01 | 2026-09-01 |
| A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients Aminolevulinic acid hydrochloride - Pediatric Brain Tumor | Phase 2 | Not yet recruiting | Costas Hadjipanayis | 20 | 2027-08-01 | 2026-10-07 |
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome NTI164, Placebo - RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Fenix Innovation Group | 40 | 2027-07-01 | 2026-09-09 |
| H3K27M-specific Immune Effector Cells Targeting DMG/DIPG H3K27M-EIEs - Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2027-06-30 | 2026-10-30 |
| The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck Nutrition counseling, Fresubin Supportan - Head &Amp;Amp; Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Anna Arthur, PhD | 15 | 2027-06-01 | 2026-08-07 |
| Memantine Targeting Neurovascular Dysfunction After Mild and Moderate Traumatic Brain Injury (MEND) Memantine - Traumatic Brain Injury, Mild Traumatic Brain Injury | Phase 2 | Not yet recruiting | Nova Scotia Health Authority | 45 | 2027-06-01 | 2026-10-09 |
| Remotely Administered tDCS to Improve Cognitive Function in Veterans With mTBI and PTSD Principal Investigator Transcranial direct current stimulation (tDCS), Cognitive training - Cognition, Brain Injuries | Phase 2 | Not yet recruiting | VA Office of Research and Development | 46 | 2027-05-24 | 2026-02-17 |
Showing 20 of 9573. Sign in to see all of them.
Brain Neoplasms (782) · Alzheimer Disease (713) · Parkinson Disease (600) · Stroke (541) · Multiple Sclerosis (382) · Ischemic Stroke (370) · Glioblastoma (353) · Central Nervous System Neoplasms (297) · Amyotrophic Lateral Sclerosis (274) · Dementia (227) · Glioma (225) · Agnosia (223) · Cognitive Dysfunction (221) · Pain (221) · Spinal Cord Injuries (216)
Central Nervous System Diseases (5646) · Brain Diseases (4870) · Pathological Conditions, Signs and Symptoms (3118) · Signs and Symptoms (2287) · Neurologic Manifestations (2257) · Neurodegenerative Diseases (2240) · Mental Disorders (1705) · Neuromuscular Diseases (1677) · Neoplasms (1527) · Neoplasms by Site (1374) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1338) · Cardiovascular Diseases (1333) · Vascular Diseases (1302) · Nervous System Neoplasms (1284)
Temozolomide (160) · Sodium Chloride (158) · Saline Solution (133) · Radiotherapy (124) · Bevacizumab (102) · Cyclophosphamide (67) · Carboplatin (59) · Dexamethasone (57) · Dexmedetomidine (57) · Transcranial Direct Current Stimulation (57) · Melatonin (55) · Botulinum Toxins, Type A (54) · Sugars (53) · Donepezil (51) · Radiosurgery (51)
National Cancer Institute (NCI) (120) · Novartis Pharmaceuticals (108) · National Institute of Neurological Disorders and Stroke (NINDS) (97) · Pfizer (84) · GlaxoSmithKline (78) · Duke University (71) · Johns Hopkins University (66) · M.D. Anderson Cancer Center (63) · VA Office of Research and Development (61) · Massachusetts General Hospital (58) · US Department of Veterans Affairs (53) · Washington University School of Medicine (52) · Brigham and Women's Hospital (50) · Assistance Publique - Hôpitaux de Paris (49) · Biogen (47)
United States (5145) · Canada (904) · France (787) · United Kingdom (776) · Germany (757) · Spain (641) · China (590) · Italy (575) · Australia (475) · Netherlands (378) · Belgium (333) · Poland (330) · Japan (249) · Israel (231) · Denmark (223)
PMID 37870112, PMID 33175411, PMID 31401903, PMID 31072380, PMID 36463457, PMID 36602886, PMID 38588457, PMID 31356217, PMID 33974419, PMID 35305920, PMID 38489195, PMID 40680102, PMID 41224659, PMID 19775921, PMID 22900785, PMID 25918556, PMID 27657681, PMID 28403842, PMID 34532852, PMID 35164991, PMID 39800465, PMID 40603145, PMID 20185783, PMID 21586746, PMID 21762873, PMID 22163120, PMID 24144944, PMID 25671797, PMID 25726502, PMID 26751635, PMID 28029918, PMID 29480210, PMID 31353964, PMID 32107748, PMID 32187457, PMID 32250312, PMID 32593547, PMID 32956407, PMID 33189083, PMID 33236783, PMID 33395098, PMID 33482890, PMID 34349180, PMID 34906976, PMID 36008843, PMID 36289001, PMID 37059702, PMID 37148485, PMID 37460385, PMID 37624739
2023 (95), 2014 (63), 2025 (61), 2017 (57), 2018 (56), 2016 (54), 2019 (54), 2015 (53), 2009 (48), 2008 (31), U10CA180886 (19), 2005 (16), 2004 (12), U10CA098543 (11), U01CA062399 (9)